![Orthocell Limited logo](/logos/OCC.AX.webp)
Orthocell Limited
ASX:OCC.AX
Overview | Financials
Company Name | Orthocell Limited |
Symbol | OCC.AX |
Currency | AUD |
Price | 0.4 |
Market Cap | 83,830,800 |
Dividend Yield | 0% |
52-week-range | 0.323 - 0.46 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Paul Frederick Anderson |
Website | https://orthocell.com |
An error occurred while fetching data.
About Orthocell Limited
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD